Jason Witherington

3.7k total citations
63 papers, 2.0k citations indexed

About

Jason Witherington is a scholar working on Molecular Biology, Organic Chemistry and Endocrine and Autonomic Systems. According to data from OpenAlex, Jason Witherington has authored 63 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 22 papers in Organic Chemistry and 7 papers in Endocrine and Autonomic Systems. Recurrent topics in Jason Witherington's work include Asymmetric Synthesis and Catalysis (9 papers), Synthetic Organic Chemistry Methods (8 papers) and Protein Degradation and Inhibitors (7 papers). Jason Witherington is often cited by papers focused on Asymmetric Synthesis and Catalysis (9 papers), Synthetic Organic Chemistry Methods (8 papers) and Protein Degradation and Inhibitors (7 papers). Jason Witherington collaborates with scholars based in United Kingdom, United States and Japan. Jason Witherington's co-authors include Rab K. Prinjha, David M. Hodgson, Kuan‐I Lee, Vincent Bordas, David G. Smith, Robert W. Ward, Robert J. Ife, Gareth J. Sanger, Brian P. Slingsby and Chun‐wa Chung and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Jason Witherington

60 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason Witherington United Kingdom 26 928 662 266 230 208 63 2.0k
Takahide Ohishi Japan 19 1.2k 1.3× 226 0.3× 152 0.6× 112 0.5× 46 0.2× 25 2.2k
R Cirillo Italy 23 1.1k 1.1× 195 0.3× 413 1.6× 43 0.2× 206 1.0× 69 2.5k
Xuntian Jiang United States 31 1.5k 1.6× 379 0.6× 124 0.5× 29 0.1× 155 0.7× 75 2.9k
Makoto Kawatani Japan 31 1.2k 1.3× 262 0.4× 244 0.9× 186 0.8× 37 0.2× 85 2.5k
Barbara Becattini Sweden 19 1.2k 1.3× 207 0.3× 201 0.8× 88 0.4× 19 0.1× 32 1.9k
Thomas Weller Switzerland 23 514 0.6× 502 0.8× 91 0.3× 429 1.9× 210 1.0× 48 2.2k
Rink‐Jan Lohman Australia 22 715 0.8× 181 0.3× 130 0.5× 36 0.2× 357 1.7× 37 1.4k
Daqing Sun China 17 463 0.5× 173 0.3× 137 0.5× 50 0.2× 164 0.8× 62 1.4k
Zhulun Wang United States 17 1.2k 1.3× 216 0.3× 183 0.7× 40 0.2× 25 0.1× 27 2.0k
Rohini Sidhu United States 25 1.3k 1.3× 289 0.4× 100 0.4× 20 0.1× 207 1.0× 39 2.7k

Countries citing papers authored by Jason Witherington

Since Specialization
Citations

This map shows the geographic impact of Jason Witherington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Witherington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Witherington more than expected).

Fields of papers citing papers by Jason Witherington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Witherington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Witherington. The network helps show where Jason Witherington may publish in the future.

Co-authorship network of co-authors of Jason Witherington

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Witherington. A scholar is included among the top collaborators of Jason Witherington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Witherington. Jason Witherington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Donegà, Matteo, Cathrine T. Fjordbakk, David M. Sokal, et al.. (2021). Human-relevant near-organ neuromodulation of the immune system via the splenic nerve. Proceedings of the National Academy of Sciences. 118(20). 34 indexed citations
2.
Campo, Miguel Del, et al.. (2019). Effect of Superior Ovarian Nerve and Plexus Nerve Sympathetic Denervation on Ovarian-Derived Infertility Provoked by Estradiol Exposure to Rats. Frontiers in Physiology. 10. 349–349. 18 indexed citations
3.
Welting, Olaf, Sybren L. Meijer, Joost H.A. Folgering, et al.. (2017). Neuronal control of experimental colitis occurs via sympathetic intestinal innervation. Neurogastroenterology & Motility. 30(3). 51 indexed citations
4.
Taylor, S., Emmanuel H. Demont, James R. Gray, et al.. (2015). Navigating CYP1A Induction and Arylhydrocarbon Receptor Agonism in Drug Discovery. A Case History with S1P 1 Agonists. Journal of Medicinal Chemistry. 58(20). 8236–8256. 13 indexed citations
5.
Park‐Min, Kyung‐Hyun, Min Joon Lee, Sung Ho Park, et al.. (2014). Inhibition of osteoclastogenesis and inflammatory bone resorption by targeting BET proteins and epigenetic regulation. Nature Communications. 5(1). 5418–5418. 110 indexed citations
6.
Prinjha, Rab K., Jason Witherington, & Kuan‐I Lee. (2012). Place your BETs: the therapeutic potential of bromodomains. Trends in Pharmacological Sciences. 33(3). 146–153. 159 indexed citations
7.
Taylor, S., James R. Gray, Robert Willis, et al.. (2012). The utility of pharmacokinetic–pharmacodynamic modeling in the discovery and optimization of selective S1P1agonists. Xenobiotica. 42(7). 671–686. 4 indexed citations
8.
Chung, Chun‐wa & Jason Witherington. (2011). Progress in the Discovery of Small-Molecule Inhibitors of Bromodomain–Histone Interactions. SLAS DISCOVERY. 16(10). 1170–1185. 35 indexed citations
9.
Ferens, Dorota, Lei Yin, Romke Bron, et al.. (2010). Functional and in situ hybridization evidence that preganglionic sympathetic vasoconstrictor neurons express ghrelin receptors. Neuroscience. 166(2). 671–679. 39 indexed citations
10.
Atcha, Zeenat, et al.. (2009). Cognitive enhancing effects of ghrelin receptor agonists. Psychopharmacology. 206(3). 415–427. 66 indexed citations
11.
Mitchell, Nicholas A., Jason Brown, Jason Witherington, et al.. (2009). 5‐hydroxyindalpine, an agonist at the putative 5‐HT1P receptor, has no activity on human recombinant monoamine receptors but accelerates distension‐induced peristalsis in mouse isolated colon. Neurogastroenterology & Motility. 21(7). 760–760. 2 indexed citations
12.
Witherington, Jason, Benjamin R. Bellenie, David K. Dean, et al.. (2008). Aryl sulphonyl amides as potent agonists of the growth hormone secretagogue (ghrelin) receptor. Bioorganic & Medicinal Chemistry Letters. 19(3). 684–687. 2 indexed citations
13.
Shafton, Anthony D., Gareth J. Sanger, Jason Witherington, et al.. (2008). Oral administration of a centrally acting ghrelin receptor agonist to conscious rats triggers defecation. Neurogastroenterology & Motility. 21(1). 71–77. 33 indexed citations
14.
Bamford, Mark J., Nicholas Bailey, Susannah Davies, et al.. (2005). (1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: A novel class of potent MSK-1-inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(14). 3402–3406. 30 indexed citations
15.
Rudd, John A., Man P. Ngan, Man K. Wai, et al.. (2005). Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin. Neuroscience Letters. 392(1-2). 79–83. 67 indexed citations
16.
Hodgson, David M., Bogdan Štefane, Timothy J. Miles, & Jason Witherington. (2004). Unsaturated 1,2-amino alcohols and ethers from aziridines and organolithiums. Chemical Communications. 2234–2235. 20 indexed citations
17.
Witherington, Jason, Vincent Bordas, Alessandra Gaiba, et al.. (2003). 6-Aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3). Bioorganic & Medicinal Chemistry Letters. 13(18). 3055–3057. 103 indexed citations
18.
Witherington, Jason, Vincent Bordas, Stephen L. Garland, et al.. (2003). 5-Aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3). Bioorganic & Medicinal Chemistry Letters. 13(9). 1577–1580. 95 indexed citations
19.
Hodgson, David M., et al.. (2002). Enantioselective Alkylative Double Ring Opening of Epoxides: Synthesis of Enantioenriched Unsaturated Diols and Amino Alcohols. Angewandte Chemie International Edition. 41(22). 4313–4316. 26 indexed citations
20.
Witherington, Jason, Vincent Bordas, Ian T. Forbes, et al.. (2001). Conformationally Restricted Indolopiperidine Derivatives as Potent CCR2B Receptor Antagonists. Bioorganic & Medicinal Chemistry Letters. 11(16). 2177–2180. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takahide Ohishi Breakdown of academic impact, for papers by R Cirillo Breakdown of academic impact, for papers by Xuntian Jiang Breakdown of academic impact, for papers by Makoto Kawatani Breakdown of academic impact, for papers by Barbara Becattini Breakdown of academic impact, for papers by Thomas Weller Breakdown of academic impact, for papers by Rink‐Jan Lohman Breakdown of academic impact, for papers by Daqing Sun Breakdown of academic impact, for papers by Zhulun Wang Breakdown of academic impact, for papers by Rohini Sidhu
Rankless by CCL
2026